Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Around the world, 3 of 4 workers who routinely handle information are now using generative AI on the job. And almost half of them are new to the technology, having begun using it only over the past half-year.
Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
It stands to reason that the branch of healthcare most reliant on the use of language in clinical practice would embrace large language AI. But is U.S. mental healthcare on board with the notion?
Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it.
A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.
Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.